PURA ANNOUNCES CBD CRYSTAL EXTRACT
June 28 2016 - 01:04PM
InvestorsHub NewsWire
Puration Announces CBD Crystal Extract
Dallas, TX - June 28, 2016 – InvestorsHub NewsWire
-- Puration, Inc. (PURA) today announced a Cannabidiol (CBD)
Crystal Extract. CBD’s therapeutic potential was recognized
and acknowledged last year in a National Institute on Drug Abuse
Senate Caucus on International Narcotics Control.
Puration began one year ago to develop the commercial application
of a U.S. Patented cannabis extraction process. Various
extracts derived from the patented process have been trialed with
positive results in the treatment of illnesses including veterans
suffering from PTSD, children with autism, various types of cancer,
patients with a variety of neurological disorders, pain management,
auto-immune disorders and seizures due to Epilepsy.
The CBD Crystal Isolate Extract announced today is the latest
benchmark in the Company’s ongoing campaign to develop a line of
commercial applications from a variety of cannabis extracts.
The Company has already begun testing of the Crystal Isolate.
Independent research suggests a water soluble CBD product may
demonstrate better bioavailability than an oil delivered CBD
product.
Learn more about Puration,
Inc. and keep up to
date on the rapid changes anticipated throughout 2016 on the
Company's website: http://www.purationinc.com/.
Puration, Inc.
Brian Shibley
+1-972-528-0162
Email: Info@purationinc.com
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2023 to Mar 2024